Colorectal cancer is one of the most common malignant diseases in the United States and
worldwide, and it remains among the top three causes of cancer-related death. A new …

Background Recently, the distinction between left-and right-sided colon cancer (LCC and
RCC) has been brought into focus. RCC is associated with an inferior overall survival and …

Background In rectal cancer, anastomotic leakage was reported to have a negative impact
on both short-and long-term outcomes. However, there is limited data on the impact of …

Background The reported outcomes of locoregionally recurrent colon cancer (LRCC) are
poor, but the literature about LRCC is scarce and aged. Recent population-based studies to …

Mountain of studies has showed that right‐sided colon cancer (RSCC) and left‐sided colon
cancer (LSCC) have different clinical presentation and biologic features and should be …

Objectives Although colorectal cancer bowel segment location has been shown to
independently predict the outcomes in early stage disease, it has not been previously …

An integrated treatment strategy using peritonectomy procedures plus hyperthermic
intraperitoneal chemotherapy (HIPEC) is now a clinical standard of care in selected patients …

Background: Colorectal cancer (CRC) is the third most common cancer worldwide.
Accurately identifying stage II CRC patients at risk for recurrence is an unmet clinical need …

Secretory leukocyte protease inhibitor (SLPI) is a pleiotropic protein produced by healthy
intestinal epithelial cells. SLPI regulates NF-κB activation, inhibits neutrophil proteases and …

Introduction Despite the oncologic safety of laparoscopic surgery in colon cancer
management, laparoscopy is not regarded as a standard treatment for T4 colon cancer. The …